Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hilton, E.
space
  arrow  Sood, S.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Ocular Lyme Borreliosis Diagnosed by Polymerase Chain Reaction on Vitreous Fluid

right arrow Eileen Hilton, MD; Candace Smith, PharmD; and Sunil Sood, MD

1 September 1996 | Volume 125 Issue 5 | Pages 424-425


TO THE EDITOR:

We describe a 26-year-old woman from Suffolk County, New York, who had pars planitis caused by Borrelia burgdorferi infection, as confirmed by polymerase chain reaction (PCR) on vitreous fluid. Results of serum Lyme enzyme-linked immunosorbent assay (ELISA), VDRL, and Mantoux tests were nonreactive. Serum IgG immunoblot for Lyme disease showed faint reactivity to the 34-, 41-, 60-, and 61-kDa proteins. Doxycycline (100 mg orally twice daily) was given as empirical treatment for Lyme disease. Visual acuity in the right eye improved from 20/400 to 20/200. After 2 months, however, the patient's vision in the left eye deteriorated to 20/80, with keratitis and inflammation.

Intravenous ceftriaxone (2 g/d) was initiated, and symptoms dramatically improved (visual acuity in the left eye, 20/50; visual acuity in the right eye, 20/25 after 4 days). On the tenth day, inflammation had regressed, but ceftriaxone therapy was discontinued because of severe thrombocytopenia. A 2-month course of treatment with oral macrolides was completed. Results of a repeat serum ELISA and immunoblot were positive (23-, 27-, 41-, 66-, 75-, and 83-kDa bands).

Because of visual deterioration during the next 6 months, vitrectomy was done on the patient's right eye. Culture of vitreous fluid was negative, but B. burgdorferi DNA was detected by PCR. The target was a 232 base-pair segment specific for B. burgdorferi [1]. Precautions used to avoid false-positive results were positive displacement pipettes and separate rooms for set up, reaction, and analysis of products. To avoid false-negative results, we used reaction mix without template and haemophilus DNA. We also ran two controls on patients with diabetic retinopathy. Products were visualized on an ethidium bromide agarose gel and were confirmed by Southern blot using an oligonucleotide probe.

Many reports have described ocular Lyme disease, some with negative vitreous cultures [2-5]. This condition may result from antibiotic therapy or a paucity of spirochetes. Specific demonstration of the organism is important, because seropositivity to B. burgdorferi may simply indicate previous or resolved infection. We propose that PCR be added to the diagnostic tests done on vitreous fluid in patients evaluated for ocular Lyme disease.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Long Island Jewish Medical Center, New Hyde Park, NY 11042


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Bradley JF, Johnson RC, Goodman JL. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med. 1994; 120:487-9.

2. Steere AC, Duray PH, Kauffman DJ. Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med. 1985; 103:382-4.

3. Kauffmann JH, Wormser GP. Ocular Lyme disease: case report and review of the literature. Br J Ophthalmol. 1990; 74:325-7.

4. Lesser RL. Ocular manifestations of Lyme disease. Am J Med. 1995; 98(Suppl 4A):60S-1S.

5. Schubert HD, Greenebaum E, Neu HC. Cytologically proven seronegative Lyme choroiditis and vitritis. Retina. 1994; 14:39-43.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hilton, E.
space
  arrow  Sood, S.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online